Comparison of the effect of vasoactive intestinal polypeptide and non-adrenergic non-cholinergic neurone stimulation in the cat gastric fundus.
The possible involvement of vasoactive intestinal polypeptide (VIP) in the non-adrenergic non-cholinergic (NANC) relaxation of the cat gastric fundus was studied in circular and longitudinal muscle strips. Cumulative transmural stimulation induced a frequency-dependent relaxation, while cumulative administration of VIP induced a concentration-dependent relaxation. Tetrodotoxin almost completely antagonized the relaxation induced by transmural stimulation (1 Hz), but did not influence the relaxation induced by VIP (10(-7) M); the latter was not influenced by hexamethonium or propranolol plus phentolamine. Trypsin (30 min incubation) and VIP antiserum (1 h incubation) prevented the relaxation induced by VIP and reduced that induced by transmural stimulation, but did not influence the relaxation induced by isopropylnoradrenaline. Two putative VIP receptor antagonists, [AcTyr1]hGRF-(1-40)OH and [4Cl-D-Phe6,Leu17]VIP, did not influence the relaxation induced by VIP or transmural stimulation. These results are compatible with the hypothesis that VIP is involved in the NANC relaxation of the cat gastric fundus, although participation of a non-VIP component cannot be excluded.
D'Amato
M
M
Heymans Institute of Pharmacology, University of Gent Medical School, Belgium.
De Beurme
F A
FA
Lefebvre
R A
RA
D000818:Animals; D000906:Antibodies / Q000276:immunology; D001341:Autonomic Nervous System / Q000502:physiology*; D002415:Cats; D004558:Electric Stimulation; D005260:Female; D005748:Gastric Fundus / Q000187:drug effects / Q000502:physiology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects* / Q000502:physiology; D009474:Neurons / Q000502:physiology*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects; D013779:Tetrodotoxin / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology; D014660:Vasoactive Intestinal Peptide / Q000276:immunology / Q000494:pharmacology*
D000906:Antibodies; D006584:Hexamethonium Compounds; D014660:Vasoactive Intestinal Peptide; D013779:Tetrodotoxin; D011433:Propranolol; D014357:Trypsin; D010646:Phentolamine